Macrophage Migration Inhibitory Factor and Autism Spectrum Disorders
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Autistic spectrum disorders are childhood neurodevelopmental disorders characterized by social and communicative impairment and repetitive and stereotypical behavior. Macrophage migration inhibitory factor (MIF) is an upstream regulator of innate immunity that promotes monocyte/macrophage-activation responses by increasing the expression of Toll-like receptors and inhibiting activation-induced apoptosis. On the basis of results of previous genetic linkage studies and reported altered innate immune response in autism spectrum disorder, we hypothesized that MIF could represent a candidate gene for autism spectrum disorder or its diagnostic components. METHODS: Genetic association between autism spectrum disorder and MIF was investigated in 2 independent sets of families of probands with autism spectrum disorder, from the United States (527 participants from 152 families) and Holland (532 participants from 183 families). Probands and their siblings, when available, were evaluated with clinical instruments used for autism spectrum disorder diagnoses. Genotyping was performed for 2 polymorphisms in the promoter region of the MIF gene in both samples sequentially. In addition, MIF plasma analyses were conducted in a subset of Dutch patients from whom plasma was available. RESULTS: There were genetic associations between known functional polymorphisms in the promoter for MIF and autism spectrum disorder-related behaviors. Also, probands with autism spectrum disorder exhibited higher circulating MIF levels than did their unaffected siblings, and plasma MIF concentrations correlated with the severity of multiple autism spectrum disorder symptoms. CONCLUSIONS: These results identify MIF as a possible susceptibility gene for autism spectrum disorder. Additional research is warranted on the precise relationship between MIF and the behavioral components of autism spectrum disorder, the mechanism by which MIF contributes to autism spectrum disorder pathogenesis, and the clinical use of MIF genotyping.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In addition, peripheral blood monocytes and macrophages from ASD individuals are hyperresponsive to stimulation as compared to those isolated from neurotypical controls, and the microbiota fundamentally regulates systemic myeloid development and differentiation (77, 78).”
From Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder (2017) · cites this paper as [77]
Experimental — accuracy not yet measuredIn the citing paper
“In addition, peripheral blood monocytes and macrophages from ASD individuals are hyperresponsive to stimulation as compared to those isolated from neurotypical controls, and the microbiota fundamentally regulates systemic myeloid development and differentiation (77, 78).”
From Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder (2017) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Research Workers
(1945) · American Journal of Clinical Pathology · doi:10.1093/ajcp/15.11.552b · Cited by 10,880
Statistical Methods for Meta-Analysis
Wasserman, S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,326
Lord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149
Lord, C., Rutter, M., Goode, S., Heemsbergen, J., Jordan, H., Mawhood, L., & Schopler, E. (1989) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02211841 · Cited by 2,030
Macrophage migration inhibitory factor: a regulator of innate immunity
Calandra, T., & Roger, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1200 · Cited by 1,795
Mapping autism risk loci using genetic linkage and chromosomal rearrangements
The Autism Genome Project Consortium (2007) · Nature Genetics · doi:10.1038/ng1985 · Cited by 1,402
Replicating genotype–phenotype associations
NCI-NHGRI Working Group on Replication in Association Studies, Chanock, S. J., Manolio, T., Boehnke, M., Boerwinkle, E., Hunter, D. J., Thomas, G., Hirschhorn, J. N., Abecasis, G., Altshuler, D., et al. (2007) · Nature · doi:10.1038/447655a · Cited by 1,352
Prevalence of Autism in a US Metropolitan Area
Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003) · JAMA · doi:10.1001/jama.289.1.49 · Cited by 1,248
Muhle, R., Trentacoste, S. V., & Rapin, I. (2004) · Pediatrics · doi:10.1542/peds.113.5.e472 · Cited by 1,207
Cited by
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.08.003 · Cited by 940
“, 2008a), macrophage inhibitory factor (Grigorenko et al., 2008), platelet–endothelial adhesion molecule (Tsuchiya et al.”
BackgroundThe Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
The role of immune dysfunction in the pathophysiology of autism
Onore, C., Careaga, M., & Ashwood, P. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.08.007 · Cited by 635
Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder
Vuong, H. E., & Hsiao, E. Y. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.08.024 · Cited by 595
Cytokine dysregulation in autism spectrum disorders (ASD): Possible role of the environment
Goines, P. E., & Ashwood, P. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2012.07.006 · Cited by 314
Differential monocyte responses to TLR ligands in children with autism spectrum disorders
Enstrom, A. M., Onore, C. E., Van de Water, J. A., & Ashwood, P. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.08.001 · Cited by 294
“In addition, several potential genetic mechanisms that impact immune function and responses have been implicated, such as complement C4B null allele (Odell et al., 2005; Samano et al., 2004), MET (Campbell et al., 2007), MIF (Grigorenko et al., 2008) reelin (Persico et al., 2001; Skaar et al., 2005), and certain human…”
Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., & Van de Water, J. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.025 · Cited by 279
“However, a clear pattern has emerged over several studies that shows altered levels of immune mediators are associated with increased impairments in behaviors (Ashwood et al., 2008; Ashwood et al., 2010; Grigorenko et al., 2008; Tsuchiya et al., 2007; Enstrom et al., 2009b; Onore et al., 2009) and suggests that a dysr…”
BackgroundAltered T cell responses in children with autism
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.09.002 · Cited by 281
“…et al., 2006; Warren et al., 1992, 1995), as well as a number of other immune-related genes including macrophage migration inhibitory factor (MIF) (Grigorenko et al., 2008), MET tyrosine receptors (Campbell et al., 2006, 2007; Garbett et al., 2008), serine and threonine kinase C gene PRKCB1…”
BackgroundPlasma Cytokine Profiles in Subjects with High-Functioning Autism Spectrum Disorders
Suzuki, K., Matsuzaki, H., Iwata, K., Kameno, Y., Shimmura, C., Kawai, S., Yoshihara, Y., Wakuda, T., Takebayashi, K., Takagai, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020470 · Cited by 252
The immune system's role in the biology of autism
Goines, P., & Van de Water, J. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283373514 · Cited by 245
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Morris, G., & Berk, M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0310-y · Cited by 245
de Theije, C. G. M., Wu, J., da Silva, S. L., Kamphuis, P. J., Garssen, J., Korte, S. M., & Kraneveld, A. D. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.07.013 · Cited by 202
“The high plasma MIF levels were positively correlated to autistic behavior (Grigorenko et al., 2008).”
BackgroundImmune dysfunction and neuroinflammation in autism spectrum disorder
Bjørklund, G., Saad, K., Chirumbolo, S., K. Kern, J., A. Geier, D., R. Geier, M., & A. Urbina, M. (2016) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2017-025 · Cited by 189
D-dopachrome tautomerase (D-DT or MIF-2): Doubling the MIF cytokine family
Merk, M., Mitchell, R. A., Endres, S., & Bucala, R. (2012) · Cytokine · doi:10.1016/j.cyto.2012.03.014 · Cited by 176
Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
Robinson-Agramonte, M. D. L. A., Noris García, E., Fraga Guerra, J., Vega Hurtado, Y., Antonucci, N., Semprún-Hernández, N., Schultz, S., & Siniscalco, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063033 · Cited by 176
Immune Dysfunction in Autism: A Pathway to Treatment
Careaga, M., Van de Water, J., & Ashwood, P. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.003 · Cited by 159
In Search of Cellular Immunophenotypes in the Blood of Children with Autism
Ashwood, P., Corbett, B. A., Kantor, A., Schulman, H., Van de Water, J., & Amaral, D. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019299 · Cited by 140
Asadabadi, M., Mohammadi, M.-R., Ghanizadeh, A. J., Modabbernia, A., Ashrafi, M., Hassanzadeh, E., Forghani, S., & Akhondzadeh, S. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2796-8 · Cited by 153
Autoantibodies to cerebellum in children with autism associate with behavior
Goines, P., Haapanen, L., Boyce, R., Duncanson, P., Braunschweig, D., Delwiche, L., Hansen, R., Hertz-Picciotto, I., Ashwood, P., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.11.017 · Cited by 134
“Previous studies have similarly shown that differences in other immune factors such as cytokines levels and total IgG correlate with behavioral severity among children with an autism spectrum disorder (Ashwood et al., 2008a,b; Grigorenko et al., 2008; Heuer et al., 2008).”
BackgroundResultThe Golgi-Associated Protein p115 Mediates the Secretion of Macrophage Migration Inhibitory Factor
Merk, M., Baugh, J. A., Zierow, S., Leng, L., Pal, U., Lee, S. J., Ebert, A., Mizue, Y., Trent, J. O., Mitchell, R. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803710 · Cited by 136
Immune Abnormalities in Autism Spectrum Disorder—Could They Hold Promise for Causative Treatment?
Gładysz, D., Krzywdzińska, A., & Hozyasz, K. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0822-x · Cited by 127
Mast cell activation and autism
Theoharides, T. C., Angelidou, A., Alysandratos, K.-D., Zhang, B., Asadi, S., Francis, K., Toniato, E., & Kalogeromitros, D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.017 · Cited by 125
Immune dysregulation in autism spectrum disorder
Noriega, D. B., & Savelkoul, H. F. J. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-2183-4 · Cited by 139
Sreih, A. G., Ezzeddine, R., Leng, L., LaChance, A., Yu, G., Mizue, Y., Subrahmanyan, L., Pons‐Estel, B. A., Abelson, A.-K., Gunnarsson, I., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30624 · Cited by 115
Association of Peripheral Blood Levels of Cytokines With Autism Spectrum Disorder: A Meta-Analysis
Zhao, H., Zhang, H., Liu, S., Luo, W., Jiang, Y., & Gao, J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.670200 · Cited by 109
Enstrom, A. M., de Water, J. V., & Ashwood, P. (2009) · PubMed · Cited by 128
Dynamic Akt/mTOR Signaling in Children with Autism Spectrum Disorder
Onore, C. E., Yang, H. T., de Water, J. V., & Ashwood, P. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00043 · Cited by 104
Conboy, L., Varea, E., Castro, J. E., Ouertatani-Sakouhi, H., Calandra, T., Lashuel, H. A., & Sandi, C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.15 · Cited by 96
Immune Dysregulation in Autism Spectrum Disorder
Hsiao, E. Y. (2013) · International Review of Neurobiology · doi:10.1016/b978-0-12-418700-9.00009-5 · Cited by 87
Sethi, R., Gómez‐Coronado, N., Walker, A. J., Robertson, O. D., Agustini, B., Berk, M., & Dodd, S. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00605 · Cited by 100
Chen, M., Su, T., Chen, Y.-S., Hsu, J.-W., Huang, K., Chang, W.-H., Chen, T., & Bai, Y. (2012) · Research in Autism · doi:10.1016/j.rasd.2012.08.008 · Cited by 93
Leyton-Jaimes, M. F., Kahn, J., & Israelson, A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.06.021 · Cited by 88
Autism: an emerging ‘neuroimmune disorder’ in search of therapy
Theoharides, T. C., Kempuraj, D., & Redwood, L. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903107789 · Cited by 79
Shin, M. S., Kang, Y., Wahl, E. R., Park, H., Lazova, R. Z., Leng, L., Mamula, M. J., Krishnaswamy, S., Bucala, R., & Kang, I. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40672 · Cited by 83
Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder
Napolioni, V., Ober-Reynolds, B., Szelinger, S., Corneveaux, J. J., Pawlowski, T., Ober-Reynolds, S., Kirwan, J., Persico, A. M., Melmed, R. D., Craig, D. W., et al. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-38 · Cited by 76
Autism Overflows: Increasing Prevalence and Proliferating Theories
Waterhouse, L. H. (2008) · Neuropsychology Review · doi:10.1007/s11065-008-9074-x · Cited by 88
MIF, MIF Alleles, and Prospects for Therapeutic Intervention in Autoimmunity
Bucala, R. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9781-1 · Cited by 80
Biomarkers for Psychiatric Disorders: Where Are We Standing?
Martins‐de‐Souza, D. (2013) · Disease Markers · doi:10.1155/2013/321071 · Cited by 84
Similarities in features of autism and asthma and a possible link to acetaminophen use
Becker, K. G., & Schultz, S. T. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2009.08.033 · Cited by 69
Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus
Yao, J., Leng, L., Sauler, M., Fu, W., Junsong, Z., Zhang, Y., Du, X., Yu, X., Lee, P. J., & Bucala, R. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81937 · Cited by 69
Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders
Onore, C., Enstrom, A., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., de Water, J. V., & Ashwood, P. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.09.005 · Cited by 67
Autism and immune factors: A comprehensive review
Stigler, K. A., Sweeten, T. L., Posey, D. J., & McDougle, C. J. (2009) · Research in Autism · doi:10.1016/j.rasd.2009.01.007 · Cited by 70
Onore, C. E., Nordahl, C. W., Young, G. S., Van de Water, J. A., Rogers, S. J., & Ashwood, P. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.004 · Cited by 65
Bridging the Gap Between Physical Health and Autism Spectrum Disorder
Sala, R., Amet, L., Blagojevic-Stokic, N., Shattock, P., & Whiteley, P. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s251394 · Cited by 99
Bashir, S., & AL-Ayadhi, L. Y. (2013) · Pediatric Research · doi:10.1038/pr.2013.248 · Cited by 67
Theoretical aspects of autism: biomarkers—a review
Ratajczak, H. V. (2011) · Journal of Immunotoxicology · doi:10.3109/1547691x.2010.538749 · Cited by 57
Cristiano, C., Lama, A., Lembo, F., Mollica, M. P., Calignano, A., & Mattace Raso, G. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00184 · Cited by 58
Autism, Gut-Blood-Brain Barrier, and Mast Cells
Theoharides, T. C., & Doyle, R. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181845f48 · Cited by 54
Distinct Cytokine and Chemokine Profiles in Autism Spectrum Disorders
Han, Y. M. Y., Cheung, W. K. Y., Wong, C. K., Sze, S. L., Cheng, T. W. S., Yeung, M. K., & Chan, A. S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00011 · Cited by 54
Common Genetic Variants Found in HLA and KIR Immune Genes in Autism Spectrum Disorder
Torres, A., Sweeten, T. L., Johnson, R. C., Odell, D., Westover, J. B., Bray‐Ward, P., Ward, D. C., Davies, C. J., Thomas, A. J., Croen, L., et al. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00463 · Cited by 65
HLA-class II haplotypes and Autism Spectrum Disorders
Bennabi, M., Gaman, A., Delorme, R., Boukouaci, W., Manier, C., Scheid, I., Mohammed, N. S., Bengoufa, D., Charron, D. J., Krishnamoorthy, R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25974-9 · Cited by 56
Patel, N. S., Crider, A., Pandya, C. D., Ahmed, A. O., & Pillai, A. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9178-2 · Cited by 54
Nudel, R., Benros, M. E., Krebs, M. D., Allesøe, R. L., Lemvigh, C. K., Bybjerg‐Grauholm, J., Børglum, A. D., Daly, M. J., Nordentoft, M., Mors, O. N., et al. (2019) · European Journal of Human Genetics · doi:10.1038/s41431-019-0402-9 · Cited by 52
Modeling autism: a systems biology approach
Randolph-Gips, M. M., & Srinivasan, P. N. (2012) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-2-17 · Cited by 52
Alteration of Gut Microbiota in Autism Spectrum Disorder: An Overview
Oh, D., & Cheon, K.-A. A. (2020) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.190039 · Cited by 60
Current Progress and Challenges in the Search for Autism Biomarkers
Voineagu, I., & Yoo, H. J. (2013) · Disease Markers · doi:10.1155/2013/476276 · Cited by 45
Autism Spectrum Disorders: From Immunity to Behavior
Careaga, M., & Ashwood, P. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-62703-071-7_12 · Cited by 38
Goyal, D. K., & Miyan, J. A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00029 · Cited by 43
Jaiswal, P., Mohanakumar, K. P., & Rajamma, U. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.013 · Cited by 40
Potential Cytokine Biomarkers in Autism Spectrum Disorders
Rose, D. R., & Ashwood, P. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.14.39 · Cited by 40
Hughes, H. K., Onore, C. E., Careaga, M., Rogers, S. J., & Ashwood, P. (2022) · Brain Sciences · doi:10.3390/brainsci12020220 · Cited by 40
CD226 (DNAM-1) is associated with susceptibility to juvenile idiopathic arthritis
Reinards, T. H. C. M., Albers, H. M., Brinkman, D. M. C., Kamphuis, S. S. M., van Rossum, M. A. J., Girschick, H. J., Wouters, C. H., Hoppenreijs, E. P. A. H., Saurenmann, R. K., Hinks, A., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205138 · Cited by 35
Lampiasi, N., Bonaventura, R., Deidda, I., Zito, F., & Russo, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032703 · Cited by 43
Altered Cytokine and BDNF Levels in Individuals with Autism Spectrum Disorders
Han, Y. M. Y., Yau, S., Chan, M. M. Y., Wong, C. K., & Chan, A. S.-Y. (2022) · Brain Sciences · doi:10.3390/brainsci12040460 · Cited by 38
Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders
Perrone, M. G., Centonze, A., Miciaccia, M., Ferorelli, S., & Scilimati, A. (2020) · Molecules · doi:10.3390/molecules25225388 · Cited by 35
Male Gender Bias in Autism and Pediatric Autoimmunity
Becker, K. G. (2012) · Autism Research · doi:10.1002/aur.1227 · Cited by 29
Increased serum levels of macrophage migration inhibitory factor in autism spectrum disorders
Ning, J., Li, X., Shen, C., Zhang, Y., & Zhao, Q. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.11.015 · Cited by 24
Okazaki, S., Hishimoto, A., Otsuka, I., Watanabe, Y., Numata, S., Boku, S., Shimmyo, N., Kinoshita, M., Inoue, E., Ohmori, T., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.01.001 · Cited by 31
Nabi, S. U., Rehman, M. U., Arafah, A. M., Taifa, S., Khan, I. S., Khan, A., Rashid, S., Jan, F., Wani, H. A., & Ahmad, S. F. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221121095618 · Cited by 23
Dectin-1 Polymorphism: A Genetic Disease Specifier in Autism Spectrum Disorders?
Bennabi, M., Delorme, R., Oliveira, J., Fortier, C., Lajnef, M., Boukouaci, W., Feugeas, J., Marzais, F., Gaman, A., Charron, D. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137339 · Cited by 22
Kim, D. H. J., Iosif, A., Ramirez-Celis, A., Ashwood, P., Ames, J., Lyall, K., Berger, K. P., Croen, L., & de Water, J. V. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.05.002 · Cited by 23
Etiology of Autism the Complexity of Risk Factors in Autism Spectrum Disorder
Fett‐Conte, A. C., Bossolani-Martins, A. L., & Rosan, D. B. A. (2015) · InTech eBooks · doi:10.5772/59109 · Cited by 30
Hodges, S. L., Nolan, S. O., Tomac, L. A., Muhammad, I. D. A., Binder, M. S., Taube, J. H., & Lugo, J. N. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.112776 · Cited by 21
Liu, W., Li, L., Xia, X., Zhou, X., Du, Y., Yin, Z., & Wang, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.780747 · Cited by 26
Saxena, V., Ramdas, S., Ochoa, C. R., Wallace, D., Bhide, P., & Kohane, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048835 · Cited by 18
Profile of MIF in Developing Hippocampus: Association With Cell Proliferation and Neurite Outgrowth
Chai, X., Zhang, W., Li, L., Wu, Y., Zhu, X., & Zhao, S. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00147 · Cited by 15
Li, X. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i46.8619 · Cited by 15
Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis
Sreih, A. G., Ezzedine, R., Leng, L., Fan, J., Yao, J., Reid, D., Piecychna, M., Carette, S., Cuthbertson, D. D., Dellaripa, P. F., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40655 · Cited by 15
Pathogenesis of Autism: A Patchwork of Genetic Causes
Grigorenko, E. L. (2009) · Future Neurology · doi:10.2217/fnl.09.29 · Cited by 17
Makinodan, M., Iwata, K., Ikawa, D., Yamashita, Y., Yamamuro, K., Toritsuka, M., Kimoto, S., Okumura, K., Yamauchi, T., Yoshino, H., et al. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.12.005 · Cited by 15
The role of maternal immune activation in immunological and neurological pathogenesis of autism
Liu, K., Huang, Y., Zhu, Y., Zhao, Y., & Kong, X. (2022) · Journal of Neurorestoratology · doi:10.1016/j.jnrt.2022.100030 · Cited by 14
Chen, X., Chen, Y., Qi, D., & Cui, D. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110422 · Cited by 13
Jana, A., Nath, A., Sen, P., Kundu, S., Alghamdi, B. S. A., Abujamel, T. S., Saboor, M., Chan, W., Alexiou, A. T., Papadakis, M., et al. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08781-6 · Cited by 12
Tamouza, R., Volt, F., Richard, J., Wu, C., Bouassida, J., Boukouaci, W., Lansiaux, P., Cappelli, B., Scigliuolo, G. M., Rafii, H., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.809686 · Cited by 12
Distribution maps of d-dopachrome tautomerase in the mouse brain
Honigman, J. S., DiGregorio, K., Dedkov, E. I., Leheste, J. R., Leng, L., Bucala, R., & Torres, G. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.009 · Cited by 10
Leng, L., Siu, E., & Bucala, R. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9936-1_7 · Cited by 10
Developing a Deeper Understanding of Autism: Connecting Knowledge through Literature Mining
Macedoni-Lukšič, M., Petrič, I., Cestnik, B., & Urbančič, T. (2011) · Autism Research and Treatment · doi:10.1155/2011/307152 · Cited by 8
Unravelling the genetics of autism spectrum disorders
Sousa, I., Holt, R., Pagnamenta, A. T., & Monaco, A. P. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511973918.005 · Cited by 7
MIF functional polymorphisms are associated with acute GVHD progression and steroid-refractoriness
Aharon, A., Avni, B. R., Louzoun, D., Elias, S., Stepensky, P., Ram, R., Zuckerman, T., Meza‐Romero, R., Vandenbark, A. A., Grisariu, S., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1504976 · Cited by 7
Helminth therapy for autism under gut-brain axis- hypothesis
Arroyo-López, C. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.02.042 · Cited by 6
Kim, M., Chung, S., Yang, J.-C., Park, J., Nam, S. H., & Park, T. W. (2020) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.200013 · Cited by 9
Macrophage migration inhibitory factor in Nodding syndrome
Benedek, G., Latif, M. A. E., Miller, K., Rivkin, M., Lasu, A. A. R., Riek, L. P., Lako, R. L. L., Edvardson, S., Arbel-Alon, S., Galun, E., et al. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009821 · Cited by 7
Wu, X., Shan, L., Wang, T., & Jin, F. (2018) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/n972017-01186 · Cited by 3
Understanding on Neuroimmunology in Autism Spectrum Disorder
Depino, A. M., & Robinson‐Agramonte, M. D. L. Á. (2015) · Springer eBooks · doi:10.1007/978-3-319-16321-5_9 · Cited by 5
The Role of Serotonin in Cortical Development: Implications for Autism Spectrum Disorder
Höhmann, C. F., & Blue, M. E. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70104-1 · Cited by 3
Exploring the Potential Role of Inflammation as an Etiological Process in ASD
Elias, R., Sullivan, J. B., Lee, Y. W., & White, S. W. (2015) · Review Journal of Autism and Developmental Disorders · doi:10.1007/s40489-015-0051-z · Cited by 3
Immune Dysfunction in Autism Spectrum Disorders
Careaga, M., de Water, J. V., & Ashwood, P. (2012) · Molecular and integrative toxicology · doi:10.1007/978-1-61779-812-2_10 · Cited by 3
Immune Abnormalities and Autism Spectrum Disorders
Akintude, M. E., Heuer, L. S., & de Water, J. V. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391924-3.00016-8 · Cited by 3
Volk, T., Lukito, S., Raduà, J., Luksch, H., Roessner, V., & Beyer, N. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03659-4 · Cited by 11
El‐Mowafy, A. M. (2016) · Autism - Open Access · doi:10.4172/2165-7890.1000166 · Cited by 3
Metadata
- Authors
- Grigorenko, E. L., Han, S. S., Yrigollen, C. M., Leng, L., Mizue, Y., Anderson, G. M., Mulder, E. J., de Bildt, A., Minderaa, R. B., Volkmar, F. R., Chang, J. T., & Bucala, R.
- Affiliations
- Lomonosov Moscow State University (RU)
- Yale University (US)
- Sapporo Immuno Diagnostic Laboratory, Sapporo, Japan
- University Medical Center Groningen (NL)
- Accare/University Medical Center Groningen, University Center for Child and Adolescent Psychiatry, Groningen, Netherlands
- ORCID
- Venue
- PEDIATRICS
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2008-08-01
- Volume
- 122
- Issue
- 2
- Pages
- e438-e445
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- PMC
- PMC3816765
- OpenAlex
- W2022600227
- Cited by
- 118
- References
- 59
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 7 · 2021: 6 · 2020: 5 · 2019: 6 · 2018: 8 · 2017: 3 · 2016: 7 · 2015: 8 · 2014: 3 · 2013: 8 · 2012: 15
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- Foundation for the National Institutes of Health
- Yale University
- Child Study Center, Yale School of Medicine
- U.S. Public Health Service (HP35482)
- National Institute of Allergy and Infectious Diseases (R01AI042310, R56AI042310, AI042310)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR-049610, R01AR049610)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD03008, P01HD003008)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- macrophage migration inhibitory factor, autism spectrum disorder, genetic susceptibility, promoter polymorphism, innate immunity, autism severity, candidate genes, neurodevelopmental disorders
- MeSH terms
- Alleles, Autistic Disorder, Child, Child, Preschool, DNA Mutational Analysis, Female, Genotype, Humans, Genetic Linkage, Macrophage Migration-Inhibitory Factors, Male, Netherlands, Pedigree, Polymorphism, Genetic, Prognosis, United States, Cohort Studies, Multivariate Analysis, Gene Expression Regulation, Developmental, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.